Apoptosis induced by most stimuli proceeds through the mitochondrial pathway. One such stimulus is nutrient deprivation. In this study we studied death induced by glucose deprivation in cells deficient in Bax and Bak. These cells cannot undergo mitochondrial outer membrane permeabilization (MOMP) during apoptosis, but they undergo necrosis when treated with MOMPdependent apoptotic stimuli. We find in these cells that glucose deprivation, rather than inducing necrosis, triggered apoptosis. Cell death required caspase activation as inhibition of caspases with peptidic inhibitors prevented death. Glucose deprivationinduced death displayed many hallmarks of apoptosis, such as caspase cleavage and activity, phosphatidyl-serine exposure and cleavage of caspase substrates. Neither overexpression of Bcl-xL nor knockdown of caspase-9 prevented death. However, transient or stable knockdown of caspase-8 or overexpression of CrmA inhibited apoptosis. Cell death was not inhibited by preventing death receptor-ligand interactions, by overexpression of c-FLIP or by knockdown of RIPK1. Glucose deprivation induced apoptosis in the human tumor cell line HeLa, which was prevented by knockdown of caspase-8. Thus, we have found that glucose deprivation can induce a death receptor-independent, caspase-8-driven apoptosis, which is engaged to kill cells that cannot undergo MOMP. Apoptosis is a form of cell death required for homeostasis of human tissues. Apoptotic cells display several morphological and biochemical changes, which are a consequence of the activity of caspase proteases.
Apoptosis is a form of cell death required for homeostasis of human tissues. Apoptotic cells display several morphological and biochemical changes, which are a consequence of the activity of caspase proteases. 1 Caspases are normally inactive in the cytosol, but they become activated by dimerization and/or proteolysis by other caspases. 'Executioner' caspases such as caspase-3 are activated through cleavage by 'initiator' or 'apical' caspases, of which the best characterized are caspases-8 and -9. Caspase-8 is activated by its recruitment to the multimeric DISC (death-inducing signaling complex) in response to extracellular ligands such as Fas/CD95-ligand, TRAIL or TNF; 2 this is the death receptor, or extrinsic pathway of apoptosis. Caspase-9 is activated by dimerization after recruitment to the apoptosome, a complex of APAF1 proteins formed in response to the release of the mitochondrial protein cytochrome c into the cytosol. 3 This caspase activation cascade is called the mitochondrial or intrinsic pathway of apoptosis.
The mitochondrial pathway of apoptosis is regulated by proteins of the Bcl-2 family, which regulate the integrity of the mitochondrial outer membrane, thereby controlling cytochrome c and subsequent caspase activation. 4 Impairment of the mitochondrial pathway is common in human tumors. Cancer cells frequently overexpress the antiapoptotic proteins Bcl-2, Bcl-xL and Mcl-1, or they lack functional proapoptotic Bcl-2 family members, including Bax, Bak or both. 5 The overexpression of antiapoptotic Bcl-2 proteins not only blocks the morphological features of apoptosis, but also enables clonogenic cell survival. 6 For these reasons, cells from Bax, Bak double-knockout (DKO) mice are a suitable model to identify non-mitochondrial pathways of cell death, which may be targeted for therapy.
Bax/Bak-deficient murine embryonic fibroblasts (MEFs) are resistant to apoptosis induced by stimuli that normally kill cells through the mitochondrial pathway. 7, 8 However, some drugs such as staurosporine, etoposide, thapsigargin and tunicamycin, which kill wild-type (WT) cells in a mitochondriadependent manner, can kill Bax-, Bak-deficient cells by a slower, non-apoptotic mechanism. 9, 10 We analyzed cell death induced by glucose deprivation in these cells, as this stimulus has been shown to kill some cell lines through necrosis. 11, 12 We report here that glucose deprivation can induce death of Bax-, Bak-deficient MEFs. Surprisingly, in these cells glucose deprivation induces apoptosis that proceeds through an unconventional pathway requiring caspase-8. Our results uncover a pathway for activation of caspase-8 different than death receptor ligation, and provide new insight into the mechanism of cell death induced by nutrient deprivation.
Results
Glucose deprivation kills Bax-, Bak-deficient cells by apoptosis. Glucose deprivation has been shown to kill cells either by necrosis 11, 12 or through the mitochondrial or 'intrinsic' pathway of apoptosis. [13] [14] [15] [16] [17] We reasoned that cells deficient in Bax and Bak, which cannot die through the intrinsic pathway, 8 would undergo a rapid necrotic death when deprived of glucose, as glucose deprivation kills most cells in 24-48 h. Alternatively, it was possible that these cells could remain atrophic but alive for weeks, as it was described that Bax-, Bak-deficient hematopoietic cells, when deprived of growth factors, downregulate glucose transporter 1 but do not die for several weeks. 18 We tested whether glucose deprivation provoked cytostatic or cytotoxic effects in SV40-transformed, Bax, Bak DKO MEFs. 8 As assessed by morphology and propidium iodide (PI) incorporation, about 10% of cells appeared dead by 24 h, with approximately 75% dead cells within 72 h (Figure 1a and b) . Their WT counterparts died more rapidly, and were all dead by 48 h (Figure 1b) , suggesting that these cells die through the mitochondrial pathway.
Bax, Bak DKO MEFs can die by a non-apoptotic form of cell death in response to staurosporine, etoposide, 9, 19 alkylating DNA agents 20 and ER stressors. 10 We determined whether the form of cell death induced by glucose deprivation was apoptosis or necrosis. The morphology of dead DKO cells was different from the classical necrotic death induced by thapsigargin in these cells, 10 and was more similar to the morphology of cells dying by apoptosis induced by the combination of TNF and cycloheximide (CHX) (Figure 1a ): cells rounded up and detached from the culture plate, and they showed a reduction of volume (shrinkage). Moreover, when we incubated glucose-deprived cells in the presence of the pan-caspase inhibitor Q-VD-OPH (Q-VD), we observed a reduction in the number of dead cells as measured by morphology and PI incorporation, thus indicating that death is caspase-dependent (Figure 1a and b) . In addition, we observed that cells displayed sub-G1 DNA fragmentation, a marker of apoptosis, with similar kinetics to that of plasma membrane disruption (PI uptake) (Figure 1b) . Z-VAD-FMK (Z-VAD), an alternative pan-caspase inhibitor, inhibited both subG1 DNA fragmentation and PI incorporation. Other markers of apoptosis such as caspase-3 and PARP cleavage were observed in Bax-, Bak-deficient cells, albeit with slower kinetics than in WT cells (Figure 1c) . We stained cells with annexin V, which detects phosphatidyl-serine exposure on the surface of apoptotic cells. Glucose-deprived cells displayed annexin V binding before they became PI-positive, another indication of apoptosis (Figure 1d ). Moreover, phosphatidylserine exposure was inhibited by Q-VD.
We observed chromatin condensation after glucose deprivation (Figure 1e and f). Nuclei had a different appearance to the classical apoptotic morphology observed after treatment with TNF, or to the relaxed appearance of necrotic cells treated with thapsigargin. After glucose deprivation, DNA was condensed around the periphery of the nuclei. However, this condensation may not be directly related to caspase activation as it occurred in glucose-deprived cells treated with Q-VD. Thus, apoptosis induced by glucose deprivation in Bax-, Bakdeficient cells displayed all of the hallmarks of apoptosis analyzed, with the exception of the characteristic chromatin condensation.
Glucose deprivation-induced death is caspasedependent and does not proceed through the mitochondrial pathway. We had observed that Q-VD and Z-VAD inhibited features of cell death induced by glucose deprivation. To confirm that caspases were active in glucosedeprived DKO cells, we analyzed the cleavage of a synthetic DEVD peptide in cell extracts. Glucose deprivation induced DEVD-ase activity, which was inhibited by Q-VD (Figure 2a ). In addition, we analyzed cleavage of the effector caspase-3, which is a marker of its activation. We observed cleavage of caspase-3 in DKO cells after glucose withdrawal that was inhibited by ZVAD ( Figure 2b ). Moreover, we verified that caspases were active by analyzing the cleavage of substrates of effector caspases: co-chaperone p23 and PARP. These proteins were cleaved in a Z-VAD-inhibitable manner (Figure 2b ).
To exclude a possible effect of Z-VAD-fmk or Q-VD-OPH on proteases other than caspases, we studied the inhibition of death by other peptidic inhibitors. We observed that a panel of caspase inhibitors prevented both subG1 DNA fragmentation ( Figure 2c ) and PI incorporation (Figure 2d ). These inhibitors were more efficient in inhibiting DNA cleavage than PI uptake, suggesting that the intracellular concentrations of these compounds can inhibit some apoptotic features better than others, or that inhibition of caspases switches the form of death to necrosis in a small percent of the cells. Consistent with data reported in Jurkat cells, 21 VDVAD-fmk and LEHDfmk were less efficient than IETD-fmk, Z-VAD-fmk and Q-VD-OPH in preventing death.
Bax and Bak are required for mitochondrial outer membrane permeabilization (MOMP) during apoptosis, and cells lacking these proteins cannot release cytochrome c or undergo apoptosis in response to many stimuli, including microinjection of tBid. 8 However, it was possible that glucose deprivation activates the mitochondrial pathway through an unidentified, alternative mechanism. Therefore, we treated cells with shRNA for caspase-9 ( Figure 3a) . This treatment did not affect any of the parameters of cell death tested (Figure 3b ). Furthermore, we generated DKO cells stably overexpressing Bcl-xL. Bcl-xL inhibits MOMP during apoptosis. 22 Bulk-transduced cells (pool) and four clones were analyzed. As shown in Figure 3c , Bax, Bak DKO MEFs overexpressing Bcl-xL ( Figure 3d ) were not protected from death when compared with the parental line.
Intriguingly, although caspase inhibitors effectively blocked glucose deprivation-induced cell death in Bax, Bak DKO MEF, we did not observe this effect in WT MEF transduced with Bcl-xL (data not shown). It is possible that Bcl-xL promotes necrosis in MEF in response to glucose deprivation, similar to what has been observed in response to etoposide. 9 Alternatively, it is possible that the adaptation to the Bax, Bak double-deficient condition primes cells for a novel caspase activation mechanism. We therefore sought to identify the caspase involved in initiating cell death in this setting. Caspase-8-dependent apoptosis by lack of glucose A Caro-Maldonado et al Caspase-8 is engaged in death induced by glucose deprivation in Bax, Bak DKO MEFs and HeLa cells. In the absence of a mitochondrial pathway of apoptosis, a likely candidate for initiating the caspase cascade is caspase-8, required for death receptor-induced 23 and other forms of apoptosis. 11, 24, 25 We therefore asked whether caspase-8 was the apical caspase in glucose starvation-induced apoptosis in these cells. We generated a stable cell line expressing short hairpin RNA (shRNA) targeting caspase-8, and selected individual clones expressing low levels of caspase-8 ( Figure 4a ). As expected, these clones and the parental pool displayed decreased sensitivity to TNF when compared with cells transfected with the empty vector ( Figure 4b ). When incubated in the absence of glucose, we observed that these clones and the parental pool were less sensitive than their mock-transfected counterparts to glucose deprivation ( Figure 4c ). To exclude the possibility of an off-target effect of this construct, or a compensation effect of the stable downregulation of caspase-8, we transiently transfected two different siRNA oligonucleotides against caspase-8. We were able to achieve a moderate reduction in caspase-8 levels ( Figure 4d ). This reduction conferred a mild but reproducible protection from death ligands (data not shown) and glucose deprivation ( Figure 4e ). Knockdown of caspase-8 reduced glucose deprivation-induced cleavage of caspase-3 ( Figure 4f ).
We had observed that the peptidic caspase inhibitor IETDfmk inhibited glucose deprivation-induced death (Figure 2c and d), suggesting that the enzymatic activity of caspase-8 is required for death. However, although IETD-fmk is widely used to block caspase-8 activity, it can also inhibit effector caspases. 21 In order to test whether the enzymatic activity of mature caspase-8 is required for apoptosis in this system, we transfected DKO cells with the viral caspase inhibitor CrmA, which preferentially inhibits caspase-8, although it can also inhibit the inflammatory caspase-1.
2,26 Cells transfected with To test whether caspase-8 dependency was exclusive of Bax, Bak DKO MEF, we used siRNA to knockdown caspase-8 in established tumor lines. Although we observed no effect on glucose deprivation-induced death in the MCF7 breast cancer line (not shown), we observed an effect in HeLa cells. Knockdown of caspase-8 in HeLa cells reduced caspase-8 levels (Figure 5a) , and prevented death induced by TNF (Figure 5b) . Strikingly, this decrease in caspase-8 reduced glucose deprivation-induced cell death to the same extent than with incubation with Q-VD (Figure 5b ).
The extrinsic pathway is not involved in glucose starvation-induced apoptosis in Bax, Bak DKO cells. Caspase-8 is activated in response to death receptor ligation. It has been shown that some drugs can induce caspase-8-mediated apoptosis through the induction of death ligands such as FasL, TNF or TRAIL. [27] [28] [29] Thus, one possibility is that glucose deprivation is activating the extrinsic pathway by inducing the synthesis and/or secretion of death ligands, which might kill the cells in an autocrine manner. To explore this possibility, we analyzed by RT-PCR the mRNA levels of death ligands and used blocking antibodies against death ligands and receptors. We could not detect the expression of Fas ligand mRNA in these cells (not shown). Furthermore, we starved cells from glucose in the presence of neutralizing antibodies for Fas-ligand or Fas-Fc (Figure 6a ), which did not prevent death. TRAIL expression did not change after glucose withdrawal (Supplementary Figure S1A) . Moreover, we could not detect toxicity of TRAIL in these cells, even in the presence of CHX or upon glucose deprivation, which has been shown to sensitize human tumor cells to TRAIL 30 (Supplementary Figure S1B) . In addition, we incubated cells in the presence of anti-TRAIL or TRAIL-R-FC (Supplementary Figure S1C and D) , which did not have any effect on cell death induced by glucose deprivation.
A slight increase in TNF mRNA levels was detected (Figure 6b ). Although TNF did not kill these cells unless they were co-incubated with CHX (Figure 6c ), the possibility remained that glucose deprivation sensitizes cells to TNF. 30 To explore this possibility, we preincubated cells without glucose and then added TNF. We observed that glucose deprivation did not sensitize these cells to TNF, as the combination of glucose deprivation and TNF caused the same amount of death than glucose deprivation alone. The combination of glucose deprivation plus CHX and TNF caused additive effects on cell death numbers (Figure 6c ). In addition, we incubated glucose-deprived cells in the presence of neutralizing antibodies against TNF and TNF-R1, which did not prevent death (Figure 6d) .
In another approach to examining the possible role of the death receptor pathway in glucose deprivation-induced apoptosis in Bax, Bak DKO cells, we examined the effects of c-FLIP. Overexpression of c-FLIP inhibits caspase-8 activation at the DISC. 31 We generated Bax, Bak DKO MEF that stably overexpress c-FLIP L , and as expected, these cells were protected from TNF or anti-Fas-induced apoptosis (Figure 7a ). However, they were not protected from glucose deprivation-induced apoptosis, suggesting that caspase-8 is activated independently of a conventional death receptorinduced DISC (Figure 7b) .
Recently, a novel form of caspase-8-and FADD-mediated apoptosis has been described. 32 When TNF is combined with Smac mimetics, TNF induces the formation of a caspase-8 activation complex formed by RIPK1, FADD and caspase-8, which leads to apoptosis. Cell death mediated by this complex is poorly inhibited by FLIP. In order to test a role for RIPK1 in our system, we incubated DKO cells in the presence of Necrostatin-1 (Nec-1). Nec-1 is an allosteric inhibitor of RIPK1 kinase activity, and it inhibits RIPK1-mediated necroptosis (death receptor-mediated necrosis). As RIPK1 kinase activity is required for apoptosis induced by combination of TNF and Smac mimetics, we deprived cells of glucose in the presence of Nec-1. Incubation with Nec-1 did not prevent glucose deprivation-induced cell death (Figure 7c ). To exclude a function of RIPK1, which could not be inhibited by Nec-1, we used siRNA to knockdown RIPK1 (Figure 7d ). The resultant decrease in RIPK1 was sufficient to inhibit death induced by TNF in the presence of the Smac mimetic Compound A (Figure 7f ), but did not influence glucose deprivation-induced cell death (Figure 7e and f) . Thus, neither the classical DISC nor the second, RIPK1-dependent caspase-8 activating complex appear to be involved in glucose deprivation-induced apoptosis.
Discussion
Bax and Bak are essential mediators of apoptosis induced by most stimuli. 8 Because the mitochondrial pathway is frequently inactivated in tumor cells, it may be clinically relevant to find means to induce necrosis or mitochondriaindependent apoptosis. Glucose deprivation has been shown to induce necrosis in some cancer cell lines. We show here that SV-40-transformed MEFs with an impairment of the mitochondrial pathway can die by apoptosis upon glucose deprivation, and that this form of apoptosis is mediated by caspase-8.
Inhibition of cell metabolism by nutrient deprivation has been extensively studied as a means to preferentially kill tumor cells, because these cells display numerous alterations in metabolic pathways, including abnormal glucose and glutamine uptake. 33 Indeed, a non-metabolizable glucose analog, 2-deoxyglucose, is currently in clinical trials as an antitumor agent. Moreover, growth factors upregulate glucose uptake and metabolism to induce prosurvival and antiapoptotic effects. 13 Glucose metabolism interferes with apoptosis at different steps, regulating both the extrinsic and the intrinsic pathways in tumor cells. 17, 30, 34 Therefore, deciphering the death pathways engaged by glucose deprivation will be helpful for rational design of clinical trials with antimetabolites and molecules which inhibit growth factor signaling. Our results suggest that tumors deficient in caspase-8 may be resistant to glucose deprivation or non-metabolizable glucose analogs, opening the possibility that this protease may be a prognostic marker of success of anti-glycolytic treatments. Caspase-8 expression is frequently impaired in tumors, especially those of the brain and childhood tumors. 35, 36 An intriguing possibility raised by our findings is that perhaps Caspase-8-dependent apoptosis by lack of glucose A Caro-Maldonado et al In this work, we show that glucose deprivation induces an atypical form of caspase-8 activation in Bax-, Bak-deficient MEFs. Caspase-8 is usually activated in a DISC complex formed upon ligation of death receptors. It is worth noting that caspase-8-dependent death has been described in response to stimuli other than death receptors, 11, 24, 25 which suggests that caspase-8 can be activated in 'alternative' platforms. It is unlikely that the classical death ligand-induced DISC is formed upon glucose deprivation, as blocking interactions between death receptors and their ligands did not block death. Moreover, FLIP overexpression, which inhibits death receptor-induced apoptosis, did not inhibit apoptosis induced by glucose removal. Caspase-8 has been described to be activated in an FADDdependent manner with some stimuli, in the absence of death receptor-ligand interactions. 37 , 38 We have not been able to Caspase-8-dependent apoptosis by lack of glucose A Caro-Maldonado et al obtain conclusive results regarding the involvement of FADD as the adapter protein for caspase-8 activation after glucose deprivation. We cannot exclude that, upon glucose removal, endogenous FADD may be aggregated intracellularly, interacting with caspase-8 and promoting its activation. However, as FLIP overexpression did not prevent apoptosis in our system, we studied the possible role of RIPK1. This protein contains a death domain and forms a complex with FADD and caspase-8 upon treatment with TNF and Smac mimetics. 32 Although knockdown of RIPK1 prevented the latter form of cell death, it did not prevent apoptosis in our system, suggesting that a novel caspase-8 activating complex is formed upon glucose deprivation. One stimulus that has been shown to promote activation of caspase-8 in the cytosol is the accumulation of polyglutamine repeats. Expression of ataxin-3 with an expanded polyglutamine tract is toxic to neurons. Sá nchez et al. 39 observed that cell death is caspase-8-dependent in this system. Caspase-8 and FADD were shown to be recruited to polyglutamine inclusions, which could serve as an aggregation platform for caspase-8. As glucose is required for protein glycosylation, and impairment of glycosylation leads to accumulation of misfolded proteins, it can be speculated that glucose deprivation could promote the generation of protein inclusions, which could recruit and activate caspase-8.
The results presented here, together with other reports, indicate that glucose deprivation can kill cells in three different ways: necrosis, mitochondrial apoptosis or caspase-8-dependent apoptosis. Why some cells undergo 'uncontrolled' necrotic death while other cells undergo apoptosis is still not clear. In our system, caspase inhibitors did not support clonogenicity of glucose-deprived cells ( Supplementary   Figure 2) , indicating that this stimulus can induce caspaseindependent cell death in the same cells. We show here that HeLa cells, which are able to undergo apoptosis through the mitochondrial pathway, die in a caspase-8-dependent manner upon glucose deprivation. This suggests that the caspase-8-dependent pathway of apoptosis described here could be engaged in cells with an intact mitochondrial pathway as well as in Bcl-2 or Bcl-xL-overexpressing tumor cells. This pathway may be relevant for pathologies that involve conditions of low glucose, such as ischemia and cancer.
Materials and Methods
Cell culture and treatments. Bax, Bak DKO MEFs immortalized with V-40 8 were maintained in high-glucose pyruvate-free DMEM (Invitrogen, Prat de Llobregat, Spain) supplemented with 2 mM L-glutamine, 200 mg/ml penicillin, 100 mg/ml streptomycin sulfate and 10% FBS (Invitrogen).
For treatments, cells were plated at a concentration of 150 000/ml. and treated 24 h later, when they reached the concentration of 500 000/ml. Glucose deprivation was performed by rinsing the cells twice with glucose-free medium (Gibco/ Invitrogen) and incubating them in glucose-free medium with freshly added 2 mM glutamine and antibiotics, plus 10% FBS dialyzed against PBS. Unless specified, caspase inhibitors were added at the time of addition of glucose-free medium. Q-VD-OPH (SM Biochemicals LLC, Anaheim, CA, USA) was used at 20 mM. Other caspase inhibitors (ICN/MP) were used at 50 mM. An equal amount of DMSO (solvent) was added to the controls. Unspecified reagents were from Sigma-Aldrich (Madrid, Spain). Measurement of cell death. For analysis of viability, detached and attached cells were collected by trypsinization and subjected to FACS analysis to detect incorporation of PI 1 mg/ml (10 min incubation in PBS). For subG1 analysis, cells were washed in PBS, fixed in 70% cold ethanol while vortexing and incubated for 1-10 days at 41C. They were further washed, resuspended in PBS with 40 mg/ml PI and 100 mg/ ml RNAse A (Sigma) and incubated for 30 min at 371C before FACS analysis. Percent of dead HeLa cells was defined as the population with low FSC/SSC compared with untreated cells. Staining with Annexin V-FITC (Immunostep, Salamanca, Spain) was performed according to the manufacturer's instructions in the presence of 0.5 mg/ml PI.
Caspase activity was measured as DEVD-ase activity. Cells treated in six-well plates were lysed in lysis buffer ( Plasmids and RT-PCR. pBABE-Bcl-xL was made by insertion of the sequence of Bcl-xL into pBABE-puro. The plasmid encoding histone 2B-green fluorescent protein (GFP) was a kind gift of Dr. R Agami (The Netherlands Cancer Institute, Amsterdam, The Netherlands).
LMP vectors (Open Biosystems, Huntsville, AL, USA) encoding shRNA against murine caspases were generated by following the manufacturer's instructions. Sense sequences against caspase-9 were (5 0 to 3 0 ): I -CGCCAGAGGTTCTCAG ACCAGA, II -CGGCCACTGCCTCATCATCAAC, and against caspase-8: AACGACTGCACTGCAAATGAAA.
For RT-PCR, 1.5 Â 10 6 cells were collected, and their RNA was extracted with RNeasy kit from Qiagen (Madrid, Spain). RNA from 50 000 cells (B500 ng) was reverse-transcripted to cDNA with the high capacity cDNA reverse transcription kit from Applied Biosystems (Madrid, Spain). 15% of the resulting cDNA was used as a template in a PCR (25 cycles Transfections and generation of cell lines. Stable cell lines were generated by retroviral infection with viruses produced in Phoenix-Eco cells. Cells infected with pMX-IRES-GFP with CrmA cDNA (kindly provided by JP Medema), with LZRS-MS-IRES-eGFP encoding c-FLIPL, 40 or with shRNA against caspases were selected by sorting for GFP expression. For transient transfections, cells were rinsed with DMEM without FBS or antibiotics and incubated for 6 h with a mix of 2 ml/ml lipofectamine 2000 (Invitrogen) and plasmidic Histone-GFP DNA (1 mg) or siRNA at 100 nM except where indicated. RIPK1 and human caspase-8 were downregulated using Dharmacon (Lafayette, CO, USA) On-Target smart pool (cat. no. L-040150 and cat. no. L-003466, respectively) with Dharmafect1. Dharmacon ON-Target plus non-targeting pool was used as a control. Sense sequence of siRNA duplexes against murine caspase-8 was
[dT] (Sigma). As a control, an irrelevant siRNA oligonucleotide (pBlue, sense strain: 5 0 -GUAAGACACGACUUAUCGC-3 0 ) was used. The same sequence coupled to a fluorochrome was used to measure transfection efficiency (pBlue-FITC), which was around 80% in all cases.
Microscopy. For analysis of nuclear morphology by visualization of Histone H2A-GFP, cells were plated and treated in four-well chamber slides (Mattek, Ashland, MA, USA), which had been previously coated with fibronectin (1 mg/ml in PBS). Confocal microscopy was performed in non-fixed cells in culture medium at room temperature using a spinning disk confocal microscope (Marianas SDC imaging system, Intelligent Imaging Innovations/3i, Denver, CO, USA) with a 473 nm laser. Images were acquired using a Neofluar Â 63 1.4 NA DIC objective on a CascadeII 512 EMCCD (Photometrics, Tucson, AZ, USA) using SlideBook 4.2 software (3i). For analysis of cell morphology, cells were treated in six-well plates and visualized in an Olympus (Center Valley, PA, USA) IX70 inverted microscope with a Â 20 objective. Brightfield pictures were taken with an Olympus C-5060 camera. One tenth of the whole field is shown.
For electron microscopy, cells were fixed with 2.5% glutaraldehyde in 0.1 M pH 7.4 buffer at 41C. After fixation, samples were placed in 1% osmium tetroxide in 0.1 M pH 7.4 buffer, dehydrated in a graded series of ethyl alcohol and embedded in Spurr resin.
